Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers.

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Breast cancer metastasis is a significant cause of mortality in European females.
• Gene expression profiling reveals distinct differences between localized primary tumors and metastatic breast cancer.
• Identifying these molecular differences can aid in predicting disease prognosis and guiding therapy.

Purpose of the Study:

• To validate potential prognostic and therapeutic markers for breast cancer metastasis.
• To conduct a meta-analysis of gene expression data from metastatic and primary breast tumors.
• To identify reliable biomarkers for breast cancer diagnostics and treatment strategies.

Main Methods:

• Meta-analysis of gene expression data from 12 studies using the Genevestigator database.
• Comparison of meta-analysis findings with literature mining for established metastatic breast cancer markers.
• Assessment of the consistency of reported differential gene expression patterns.

Main Results:

• COX2 gene expression is significantly downregulated in metastatic tissue compared to normal breast tissue.
• RRM2 gene expression decreases in metastases relative to primary breast cancer, potentially tracking tumor evolution.
• MMP1, VCAM1, FZD3, VEGFC, FOXM1, and MUC1 show differential expression, supporting their role as breast cancer onset markers.

Conclusions:

• COX2 and RRM2 are proposed as prominent markers for breast cancer metastasis detection.
• Upstream regulators like p53, ER1, ERB-B2, TNF, and WNT are implicated in metastatic progression.
• These regulators represent promising targets for novel therapeutic interventions against metastatic breast cancer.